MissionIR Articles
-
Predictive Oncology Inc. (NASDAQ: POAI) Appoints New Board Member with Impressive CSO, Senior Research Background
Dan Handley brings wealth of invaluable experience to POAI’s board of directors Newest board member has extensive experience with entities closely associated with POAI’s Helomics division Predictive Oncology set to benefit from Handley’s broad knowledge,…
-
Pressure BioSciences Inc. (PBIO) Opens UST Demonstration Lab, Ushering in New Era in CBD Water-Soluble Nanoemulsion Preparation
The new facility is designed to demonstrate the company’s innovative Ultra Shear Technology’s ability to create CBD oil nanoemulsions of superior stability, aesthetics, and bioavailability Company has received orders for nine UST-based BaroShear K45 proprietary…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Official Opening of its Ultra Shear Technology(TM) Demonstration Laboratory
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics and other industries, today announced the official opening of…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Featured in Updated Research Report by Zacks SCR
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences industry, today announced that Zacks Small Cap Research (“Zacks…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Plans to Release Benchtop UST-Based BaroShear Instrument in Q3 2020
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its plans to release…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Receives Significant New Order, Expects Several More for Revolutionary Nanoemulsification System for Water-Soluble CBD Oil
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced its receipt of a…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc.’s (PBIO) Innovative UST Platform Featured in Leading North American Cannabis Publication
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide life sciences and other industries, today announced that its new and…
-
MissionIRNewsBreaks – Zacks Small Cap Research Issues Update, Maintains Price Target on Pressure BioSciences Inc. (PBIO)
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and platform-technology solutions to the life sciences and other industries, was recently covered in a research report by…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Announces Second Straight Year of Strong Publication Numbers of Scientific Papers Citing Advantages of its PCT Platform
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the life sciences and other industries, today announced that in 2019 – for…
-
Zacks Maintains Strong $4.44 Price Target for Pressure BioSciences Inc. (PBIO)
Zacks has reiterated support for their initial $4.44 share price target for Pressure BioSciences PBIO’s fundamentals remain strong, with record sales of consumables and increased revenue from products and services over same quarter previous year…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) Reports Q3 2019 Financial Results, Provides Business Update
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, services, and platform solutions to the worldwide life sciences industry, today announced financial results for the third quarter…
-
MissionIRNewsBreaks – Pressure BioSciences, Inc. (PBIO) to Host Teleconference to Discuss Q3 2019 Financial Results, Provide Business Update
Pressure BioSciences (OTCQB: PBIO) (“PBI”) today announced that it will host a teleconference to discuss its third quarter 2019 financial results and to provide a business update. According to the update, Pressure BioSciences will include…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Highlighted at IGCS Conference in Brazil
Pressure BioSciences’ (OTCQB: PBIO) patented pressure cycling technology (“PCT”) platform was recently described as an integral part of women’s cancer research efforts during a presentation at the International Gynecologic Cancer Society conference in Brazil. An…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Proprietary PCT Platform Demonstrates Ability to Discover Cancer Biomarkers in Independent Research
Pressure BioSciences’ (OTCQB: PBIO) pressure cycling technology (“PCT”) platform was recently the subject of independent research carried out by Chinese and Australian scientists in which the platform demonstrated its proficiency in processing of preserved (“FFPE”)…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) BaroShear K45 System Creates Water-Soluble CBD Oil
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, has developed a revolutionary CBD processing system, the BaroShear K45,…
-
Pressure BioSciences Inc. (PBIO) Gains Praise Amid Disclosure of Innovative Research Tool to Aid Gynecological Cancer Diagnosis, Therapy
Pressure BioSciences was described as an integral part of women’s cancer research efforts during a presentation last month at the International Gynecologic Cancer Society conference in Brazil The company’s patented pressure cycling technology provided a…
-
MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) Announces Initiation of Zacks Small Cap Research Coverage
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that Zacks Small Cap Research (“Zacks SCR”)…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Fills Integral Role for Tumor Analyses in Novel Workflow Presented at IGCS
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”)…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Patented PCT Platform Highlighted in 10 Separate Presentations at International Human Proteome Organization World Congress
Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced that its patented pressure cycling technology (“PCT”)…
-
Pressure BioSciences Inc.’s (PBIO) Proprietary Technology Platform Identified as Key Cancer Biomarker Research Element
Independent research carried out by Chinese and Australian scientists shows that the Pressure BioSciences Pressure Cycling Technology (PCT) platform is excellent for the processing of preserved (formalin-fixed paraffin-embedded, or FFPE) and fresh frozen biopsy tissues,…
Search Articles
Latest Articles
- FAVO Capital Inc. (FAVO): When Private Credit Meets Real Estate Collateralization
- AI and the Copper Conundrum: How Trilogy Metals Inc. (NYSE American: TMQ) (TSX: TMQ) Fits into the Supply Equation
- Silvercorp Metals Inc. (NYSE-A/TSX: SVM) El Domo Environmental License Upheld as Ecuador’s Constitutional Court Dismisses Final Challenge
- NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Seeks FDA Ban on Toxic Ketamine Preservative
- MissionIRNewsBreaks – Calidi Biotherapeutics Inc. (NYSE American: CLDI) Closes $6.9 Million Public Offering Including Full Over-Allotment Option